Atlas Trials

Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases

Clinical trial NCT02265549 · COMPLETED

Trial details

NCT number
NCT02265549
Sponsor
Maastricht Radiation Oncology
Status
COMPLETED
Study type
OBSERVATIONAL
Metastases, Neoplasm
Start date
2014-05-01
Primary completion
2014-09-04
Enrollment
155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.